EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer

Adam Haysom-McDowell, Keshav Raj Paudel, Stewart Yeung, Sofia Kokkinis, Tammam El Sherkawi iD, Dinesh Kumar Chellappan, Jon Adams, Kamal Dua, Gabriele De Rubis iD

Molecular Oncology · 2025-01 · 19 (1) · 15-36

DOI: 10.1002/1878-0261.13764 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 26.11.2024. Verfasst von Adam Haysom-McDowell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government, UTS Faculty of Health HDR Industry Collaboration Funding Scheme, Maridulu Budyari Gumal Sydney Partnership for Health, Education, Research and Enterprise.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the leading cause of cancer death globally, with non‐small cell lung cancer accounting for the majority (85%) of cases. Standard treatments including chemotherapy and radiotherapy present multiple adverse effects. Medicinal plants, used for centuries, are traditionally processed by methods such as boiling and oral ingestion, However, water solubility, absorption, and hepatic metabolism reduce phytoceutical bioavailability. More recently, isolated molecular compounds from these plants can be extracted with these phytoceuticals administered either individually or as an adjunct with standard therapy. Phytoceuticals have been shown to alleviate symptoms, may reduce dosage of chemotherapy and, in some cases, enhance pharmaceutical mechanisms. Research has identified many phytoceuticals' actions on cancer‐associated pathways, such as oncogenesis, the tumour microenvironment, tumour cell proliferation, metastasis, and apoptosis. The development of novel nanoparticle delivery systems such as solid lipid nanoparticles, liquid crystalline nanoparticles, and liposomes has enhanced the bioavailability and targeted delivery of pharmaceuticals and phytoceuticals. This review explores the biological pathways associated with non‐small cell lung cancer, a diverse range of phytoceuticals, the cancer pathways they act upon, and the pros and cons of several nanoparticle delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansAnimalsNanoparticlesNanoparticle Drug Delivery SystemPhytochemicalsDrug Delivery SystemsAntineoplastic Agents, Phytogenic

Stichwörter der Autor:innen

cancer pathwaysdrug delivery systemnanomedicinenon‐small cell lung cancerphytoceutical

Substanzen

Nanoparticle Drug Delivery SystemPhytochemicalsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia.
  • Australian Research Consortium in Complementary and Integrative Medicine, School of Public Health, University of Technology Sydney, Ultimo, Australia.
  • Centre for Inflammation Centenary Institute, Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
  • Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.

ORCID-Profile: Tammam El Sherkawi, Gabriele De Rubis

Förderung

  • Australian Government
  • UTS Faculty of Health HDR Industry Collaboration Funding Scheme
  • Maridulu Budyari Gumal Sydney Partnership for Health, Education, Research and Enterprise

Zitieren

APA

Haysom-McDowell, A., Paudel, K. R., Yeung, S., Kokkinis, S., El Sherkawi, T., Chellappan, D. K., Adams, J., Dua, K., & De Rubis, G. (2025). Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer. Molecular Oncology, 19(1), 15-36. https://doi.org/10.1002/1878-0261.13764

Vancouver

Haysom-McDowell A, Paudel KR, Yeung S, Kokkinis S, El Sherkawi T, Chellappan DK, et al. Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer. Molecular Oncology. 2025;19(1):15-36. doi:10.1002/1878-0261.13764

BibTeX
@article{HaysomMcDowell2025,
  author = {Haysom-McDowell, Adam and Paudel, Keshav Raj and Yeung, Stewart and Kokkinis, Sofia and El Sherkawi, Tammam and Chellappan, Dinesh Kumar and Adams, Jon and Dua, Kamal and De Rubis, Gabriele},
  title = {Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer},
  journal = {Molecular Oncology},
  year = {2025},
  volume = {19},
  number = {1},
  pages = {15--36},
  doi = {10.1002/1878-0261.13764}
}
Kostenlos starten →